List Title | APhA DrugInfoLine

Focus on Immunizations

SORT BY: Most Recent Most Viewed

November 1, 2013

Heart smart: Flu shot linked to lower risk of major cardiovascular events

READ

PREVIEW
Influenza vaccination was associated with a lower risk of major cardiovascular events in a recent analysis. A stronger association was observed in patients with recent acute coronary syndrome as...
October 12, 2013

MMR booster does not increase juvenile arthritis disease activity

READ

PREVIEW
The use of a measles-mumps-rubella (MMR) booster in children with juvenile idiopathic arthritis who have undergone primary immunization did not result in worsened juvenile idiopathic arthritis (...
July 21, 2013

Dueling articles debate necessity of influenza vaccination

READ

PREVIEW
The author of two commentaries argued that influenza is not a public health threat, vaccination is not effective and possibly unsafe, and current immunization recommendations are inaccurate. In...
May 24, 2013

Varicella vaccine protection persists in largest, longest study of effectiveness to date

READ

PREVIEW
In children who received the varicella virus vaccine (Varivax—Merck), the average incidence of varicella infection at 14 years post-vaccination was 9- to 10-fold times lower than historic...
May 20, 2013

Initiation of anti-TNF inhibitor does not increase herpes zoster risk

READ

PREVIEW
Individuals with rheumatoid arthritis (RA) and other inflammatory diseases who initiated anti-tumor necrosis factor (anti-TNF) therapy were not at greater risk of herpes zoster infection than...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.